Rustom Jilla
Analyst · William Blair. Please go ahead
Thank you, Erik. Good morning everyone. So let’s turn to our fiscal second quarter in greater detail. Our average daily sales in the second quarter increased by 2.9% versus last year, with sales to manufacturers up 2.6% and to non-manufacturers 4.5%. So overall ADS growth came in slightly above the high end of our guidance range of 2.5% and this was a very nice turnaround after five quarters of ADS decline. As Erik mentioned, our Q2 gross margins at 44.7% was slightly better than the midpoint of our guidance and down roughly 40 basis points from last year. Product and customer mix, including capital related sales were basically in line with our expectations. In mid February, we did take a small mid-year price increase in some select product categories. However, it was too late to have an impact on Q2 gross margin and too small to have much of an impact on gross margin for the rest of fiscal 2017. As always, we continue to tightly manage our operating expenses and despite approximately $20 million in higher sales year-over-year, our OPEX declined slightly. Of course, there are number of pluses and minuses. Last year's Q2 had high medical expenses, re-transition to a new medical plan and the amortization related to J&L acquisition. This year we had volume related variable cost, SAP finance project expenses, a higher bonus accrual and higher salaries due to merit increases, all partially offset by productivity saving. So this resulted in roughly 100 basis points of leverage as operating expenses as a percentage of sales decline. Now versus our guidance midpoint Q2 OPEX is about $3 million higher, roughly a $1 million was due to higher sales volume and the remainder was a combination of payroll and payroll related expenses primarily additional sales commissions and bonus accruals. Our second quarter operating margin was 12.3%, slightly better than the guidance midpoint of 12.2% but up a solid 50 basis point from last year's Q2. Our operating margin improvement versus guidance came from higher sales volume and gross margin performance while the improvement versus last year came from expense leverage. Operating income itself grew 8% on 3% growth illustrating the potential for leverage in our business model as the industrial economy returns to greater growth. Our fiscal second quarter EPS was $0.93, $0.03 above the high end of our guidance range. $0.03 of EPS was attributable to our lower effective tax rate. Our effective tax rate came in at 36.1%, well below our guidance of 38.2% and this was due to the early adoption of the new accounting standard on stock compensation, which requires excess tax benefits and deficiencies resulted from wasted or exercised stock based compensation to be recognized in the income statement. Our early adoption resulted in net excess tax benefits which were previously been recognized through additional paid and capital on the balance sheet but are now recognized as reduction of income tax expense during Q2. So Q2's EPS was up 16% from last year's Q2 of $0.80. Broadly, operating income growth contributed $0.05; the income tax benefits about $0.03 and a lower number of shares outstanding another $0.05. Turning to balance sheet, our DSO's were 51.5 days, up over the prior year and slightly down from the last quarter. Our inventory turns at 3.4 were up from last year and also up slightly from last quarter's 3.3 and this was despite inventory is increasingly sequentially by roughly $10 million. You may recollect that we signaled Q2 inventory growth on our last call. Likewise in Q3, we expect inventories to be slightly higher as we want to remain well positioned for an upturn in sales. Our free cash flow which is cash flow from operation less capital expenditure was $8 million in the second quarter. This compared to roughly $50 million for the same quarter last year. So the major drivers of this change were higher inventories and accounts receivable which can be expected in a growth environment, offset partially by higher accrued liabilities. Our capital expenditures were $13.2 million in the second quarter, up $2 million from last year's Q2. Note that our fiscal 2017 CapEx is now expected to be around $55 million to $60 million. And we continue to expect fiscal 2017's operating cash flow conversion which is net cash from operating activities divided by net income, to be about 100%. At the end of the second quarter, we had roughly $549 million in debt, mainly comprised of $184 million revolving credit facility balance, $163 million on our term loan and $175 million of private placement debt. We had $36 million in cash and cash equivalent and so our leverage ratio remains at 1.1x. Now to our guidance for the third quarter of fiscal 2017 which you can see on slide 4 of our presentation. We expect Q3 sales to be between $734 million to $748 million, up from the prior quarter's $727 million despite one less work day this quarter. So our guidance therefore assumes average daily sales of $11.6 million in Q3 and ADS growth of roughly 3.5% at the midpoint. We expect gross margin to be 44.6% plus or minus 20 basis points in Q3. And that's down 40 basis points from the prior Q3's 45% and virtually flat sequentially. And this is consistent with what we anticipated on our last call. We expect Q3's operating expenses to be above $230 million or roughly $9 million higher than the prior year. Three buckets here broadly. Variable expenses related to higher sales should amount to $1 million; the second bucket is spending on our key initiative and other items net of productivity and J&L amortization account for another $2 million. And I should point out you that both of our two large projects SAP finance and telephony peak in Q3 as they are currently being implemented. And expenses were begun to subside in Q4. The single largest driver of Q3 is increase in OPEX is roughly $6 million of bonus accruals versus last year's third quarter, which we have been talking about since last year's third quarter. If the bonus accrual and last year's extra day were normalized between the two years, Q3's OPEX as a percentage of sales would be below last year's. This is obviously at midpoint of guidance. Looking forward to Q4, at these levels of sales growth and after backing out the extra four days in last year's Q4, we expect further leverage meaning that OPEX as a percentage of sales will be below prior year. So all of this result in Q3 operating margin of about 13.5% at the midpoint of guidance. Last year's Q3 was 14.5% but if the bonus accrual and the one extra working day are normalized -- last year are normalized out then Q3's operating margin is slightly up on last year, with the mix driven lower gross margin offset by OPEX leverage. Furthermore, if Q3 ends per our guidance then year-to-date with virtually flat we'd be at an operating margin of 13%. This would be slightly ahead of the expectations contemplated in our framework which is on slide 5 in the presentation. We are assuming an effective tax rate of 36.3% for Q3. While it's difficult to predict how many stock options will be exercised in Q3 and our share price, we have estimated in our guidance that under the newly adopted accounting standard to share based compensation, there will be $0.01 EPS benefit. In addition, we've assumed the $0.02 EPS benefit from R&D tax credit mostly associated with the investment in our SAP finance implementation. So finally our EPS guidance for our fiscal third quarter of 2017 is a range of $1.05 to $1.09. I'll now turn back to Erik.